Henshaw Capital’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,820	Closed	-$80K	–	270
2022 Q4	$80K	Hold	10,820	–	–	0.01%	249
2022 Q3	$107K	Hold	10,820	–	–	0.01%	293
2022 Q2	$118K	Sell	10,820 -3,531	-25%	-$36.6K	0.01%	300
2022 Q1	$162K	Hold	14,351	–	–	0.01%	313
2021 Q4	$225K	Hold	14,351	–	–	0.01%	309
2021 Q3	$246K	Hold	14,351	–	–	0.02%	289
2021 Q2	$309K	Hold	14,351	–	–	0.02%	276
2021 Q1	$216K	Hold	14,351	–	–	0.01%	326
2020 Q4	$189K	Hold	14,351	–	–	0.01%	332
2020 Q3	$139K	Hold	14,351	–	–	0.01%	307
2020 Q2	$164K	Hold	14,351	–	–	0.01%	301
2020 Q1	$149K	Buy	+14,351	New	+$178K	0.01%	268
2019 Q4	–	Sell	-10,572	Closed	-$140K	–	302
2019 Q3	$140K	Buy	+10,572	New	+$147K	0.01%	278
2019 Q1	–	Sell	-9,705	Closed	-$254K	–	296
2018 Q4	$254K	Buy	+9,705	New	+$228K	0.02%	208